Drug Patent Expirations for the Week of June 26, 2022

   June 26, 2022    Comments Off on Drug Patent Expirations for the Week of June 26, 2022    Posted in: General Biotechnology

PRADAXA (dabigatran etexilate mesylate) Boehringer ingelheim Patent: 6,087,380 Expiration: Jun 28, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…

The post Drug Patent Expirations for the Week of June 26, 2022 appeared first on DrugPatentWatch – Make Better Decisions.

  

Comments are closed.

Biotechblog